First posted 2/24/23; updated 4/3/23

As we reach the middle of June, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and...

$XBI $70.03 | +3.58% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #OCGN +4.6% Ocugen Announces...

$XBI $70.03 | +3.58% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #OCGN +4.6% Ocugen Announces...

$XBI $71.21 | +3.55% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX -20% Novavax Statement on...

$XBI $71.21 | +3.55% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX -20% Novavax Statement on...

$XBI $68.78 | -3.25% BPIQ median | -1.84% Big Positive Movers on News #TXMD +364% TherapeuticsMD and EW Healthcare Partners Announce...

$XBI $68.78 | -3.25% BPIQ median | -1.84% Big Positive Movers on News #TXMD +364% TherapeuticsMD and EW Healthcare Partners Announce...

The 40th Annual J.P. Morgan Health Care Conference is taking place fully online from January 10-13, 2022. "This premier conference is...

Summary Over 40 Smid-Cap companies currently have active trials involving COVID therapeutics (this includes small molecules and...